Activating Mutations in the Epidermal Growth …Most patients with non–small-cell lung cancer have no response to the tyrosine kinase inhibitor gefitinib, which targets the epidermal growth factor receptor (EGFR ... http://www.nejm.org/doi/full/10.1056/NEJMoa040938